NextCure, Inc. (NXTC) income statement
NXTCNasdaqPharmaceutical PreparationsFiscal year ends December 31
$6.45−0.33 (-4.87%)
Close on Nov 20, 2026Market cap $29.52MP/E –Yield 0.00%
NextCure, Inc. financial ratios
See a number that looks wrong?
Close on Nov 20, 2026Market cap $29.52MP/E –Yield 0.00%
See a number that looks wrong?
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Margins | |||||||||
| Operating margin | – | – | – | – | – | -184.2% | -590.5% | – | – |
| EBITDA margin | – | – | – | – | – | -169.0% | -548.2% | – | – |
| Net profit margin | – | – | – | – | – | -163.6% | -531.5% | – | – |
| Free cash flow margin | – | – | – | – | – | -232.8% | -614.4% | – | – |
| Returns on capital | |||||||||
| Return on equity | -111.2% | -61.9% | -44.5% | -37.3% | -26.3% | -11.9% | -24.6% | 63.9% | – |
| Return on assets | -85.2% | -53.3% | -40.2% | -35.0% | -25.3% | -11.0% | -13.4% | -15.4% | – |
| Return on tangible assets | -85.2% | -53.3% | -40.2% | -35.0% | -25.3% | -11.0% | -13.4% | -15.4% | – |
| Return on invested capital | – | – | – | – | – | 2,226.1% | 30.3% | 10.1% | – |
| Return on capital employed | -103.9% | -62.1% | -45.7% | -37.0% | -26.6% | -12.9% | -15.7% | -16.9% | – |
| Return on total capital | – | – | – | – | – | -13.2% | -26.8% | 49.9% | – |
| NOPAT | -$45.52M | -$47.20M | -$53.43M | -$59.97M | -$55.90M | -$32.57M | -$29.61M | -$18.32M | – |
| Cash flow quality | |||||||||
| OCF / Sales | – | – | – | – | – | -200.9% | -561.3% | – | – |
| OCF / Net income | 0.89 | 0.73 | 0.84 | 0.72 | 0.83 | 1.23 | 1.06 | -0.35 | – |
| FCF / OCF | – | 101.2% | 101.5% | 103.9% | 104.1% | 115.9% | 109.5% | 61.7% | – |
| FCF / Net income | – | 0.74 | 0.86 | 0.75 | 0.86 | 1.42 | 1.16 | -0.22 | – |
| FCF / EBITDA | – | 72.6% | 84.1% | 78.0% | 89.7% | 137.7% | 112.1% | -22.9% | – |
| Unlevered free cash flow | – | -$41.28M | -$53.79M | -$56.00M | -$59.64M | -$51.94M | -$38.83M | $4.95M | – |
| Levered free cash flow | – | -$41.28M | -$53.79M | -$56.00M | -$59.64M | -$52.09M | -$38.99M | $4.93M | – |
| Efficiency | |||||||||
| Asset turnover | – | – | – | – | – | 0.07 | 0.03 | – | – |
| Fixed asset turnover | – | – | – | – | – | 1.60 | 0.54 | – | – |
| CapEx to revenue | – | – | – | – | – | 31.9% | 53.1% | – | – |
| CapEx to OCF | – | -1.2% | -1.5% | -3.9% | -4.1% | -15.9% | -9.5% | 38.3% | – |
| CapEx to depreciation | – | 0.16 | 0.22 | 0.52 | 0.55 | 2.10 | 1.25 | 1.83 | – |
| Liquidity | |||||||||
| Current ratio | 4.14 | 7.50 | 16.38 | 17.97 | 34.48 | 27.89 | 22.60 | 13.19 | – |
| Quick ratio | 4.14 | 7.50 | 16.38 | 17.97 | 34.48 | 27.89 | 22.60 | 13.19 | – |
| Cash ratio | 2.46 | 2.90 | 1.90 | 2.92 | 1.87 | 27.79 | 22.58 | 13.17 | – |
| Working capital | $33.18M | $62.23M | $105.84M | $154.86M | $221.21M | $277.65M | $324.95M | $125.49M | – |
| Net current asset value | $28.51M | $56.42M | $99.11M | $147.35M | $218.82M | $275.06M | $305.31M | $103.44M | – |
| Leverage | |||||||||
| Total debt | – | – | – | – | – | $3.47M | $5.00M | $460.00K | – |
| Net debt | – | – | – | – | – | -$283.49M | -$334.64M | -$135.17M | – |
| Debt / Equity | – | – | – | – | – | 0.01 | 0.02 | -0.01 | – |
| Debt ratio | – | – | – | – | – | 1.1% | 1.4% | 0.31% | – |
| Assets to equity | 1.44 | 1.24 | 1.12 | 1.10 | 1.04 | 1.04 | 1.11 | -3.14 | – |
| Long-term debt to assets | – | – | – | – | – | 0.59% | 0.94% | 0.05% | – |
| Long-term debt to equity | – | – | – | – | – | 0.01 | 0.01 | -0.00 | – |
| Total debt / Capitalization | – | – | – | – | – | 1.2% | 1.5% | -0.99% | – |
| Long-term debt / Capitalization | – | – | – | – | – | 0.61% | 1.0% | -0.16% | – |
| Net debt / EBITDA | – | – | – | – | – | 7.49 | 9.62 | 6.28 | – |
| Total debt / EBITDA | – | – | – | – | – | -0.09 | -0.14 | -0.02 | – |
| Cash flow to debt | – | – | – | – | – | -1,294.4% | -712.5% | 1,737.4% | – |
| Interest coverage | |||||||||
| EBIT / Interest expense | – | – | – | – | – | -225.27 | -179.34 | -927.84 | – |
| EBITDA / Interest expense | – | – | – | – | – | -206.69 | -166.48 | -860.76 | – |
| (EBITDA − CapEx) / Interest expense | – | – | – | – | – | -245.67 | -182.61 | -983.28 | – |
| Per share | |||||||||
| Revenue per share | – | – | – | – | – | 9.74 | 2.77 | – | – |
| EPS (basic) | -19.65 | -23.88 | -27.00 | -32.28 | -30.12 | -15.96 | -25.80 | -199.68 | – |
| EPS (diluted) | -19.65 | -23.88 | -27.00 | -32.28 | -30.12 | -15.96 | -25.80 | -199.68 | – |
| Book value per share | 9.97 | 28.05 | 49.21 | 72.38 | 101.18 | 127.85 | 140.29 | -409.75 | – |
| Tangible book value per share | 9.97 | 28.05 | 49.21 | 72.38 | 101.18 | 127.85 | 140.29 | -409.75 | – |
| Cash per share | 7.41 | 11.88 | 5.63 | 11.51 | 5.35 | 124.91 | 148.21 | 1,183.86 | – |
| Operating cash flow per share | -14.15 | -17.48 | -22.78 | -23.28 | -24.83 | -19.57 | -15.55 | 69.76 | – |
| Free cash flow per share | – | -17.69 | -23.13 | -24.20 | -25.86 | -22.67 | -17.02 | 43.02 | – |
| CapEx per share | – | 0.20 | 0.35 | 0.91 | 1.02 | 3.10 | 1.47 | 26.74 | – |
| Valuation at period end | |||||||||
| Market cap | $37.97M | $21.57M | $31.74M | $39.13M | $165.73M | $300.34M | $1.28B | – | – |
| Enterprise value | $30.65M | -$6.13M | $12.22M | $8.04M | $129.02M | $9.10M | $1.10B | – | – |
| P/S | – | – | – | – | – | 13.4x | 202x | – | – |
| P/B | 1.1x | 0.3x | 0.3x | 0.2x | 0.7x | 1.0x | 4.0x | – | – |
| P/TBV | 1.1x | 0.3x | 0.3x | 0.2x | 0.7x | 1.0x | 4.0x | – | – |
| P/OCF | -0.8x | -0.5x | -0.6x | -0.7x | -2.9x | -6.7x | -36.0x | – | – |
| EV/Sales | – | – | – | – | – | 0.4x | 173x | – | – |
| EV/EBIT | – | 0.1x | – | – | – | – | – | – | – |
| EV/OCF | -0.6x | 0.2x | -0.2x | -0.1x | -2.3x | -0.2x | -30.8x | – | – |
| EV/FCF | – | 0.1x | – | – | – | – | – | – | – |
| Earnings yield | -147.1% | -258.0% | -197.6% | -191.0% | -41.9% | -12.2% | -2.6% | – | – |
| FCF yield | – | -191.4% | -169.5% | -143.1% | -36.0% | -17.3% | -3.0% | – | – |
| Shareholder yield | |||||||||
| Dividend per share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | – | – |
| Dividend yield | – | – | – | – | – | 0.00% | 0.00% | – | – |
| Debt paydown yield | – | – | – | – | 2.1% | 0.51% | – | – | – |
| Cost structure | |||||||||
| R&D to revenue | – | – | – | – | – | 208.0% | 539.1% | – | – |
| Stock-based comp to revenue | – | – | – | – | – | 35.4% | 29.7% | – | – |
| Per employee | |||||||||
| Total employees | 40 | 43 | 82 | 99 | 87 | 90 | 69 | 69 | 69 |
| Revenue per employee | – | – | – | – | – | $248.64K | $91.99K | – | – |
| Operating profit per employee | -$1.44M | -$1.39M | -$824.84K | -$766.76K | -$813.39K | -$458.06K | -$543.22K | -$336.17K | – |
| Net income per employee | -$1.40M | -$1.29M | -$764.91K | -$754.88K | -$797.57K | -$406.70K | -$488.94K | -$330.42K | – |
| Free cash flow per employee | – | -$959.98K | -$656.02K | -$565.68K | -$685.55K | -$578.73K | -$565.13K | $71.43K | – |
| Growth | |||||||||
| Revenue 1Y growth | – | – | – | – | – | 252.6% | – | – | – |
| EBIT 1Y growth | 3.6% | 11.7% | 10.9% | -7.3% | -71.7% | -10.0% | -61.6% | – | – |
| EBITDA 1Y growth | 2.5% | 11.1% | 11.0% | -8.0% | -75.7% | -8.7% | -61.7% | – | – |
| Net income 1Y growth | -0.34% | 11.3% | 16.1% | -7.7% | -89.6% | -8.5% | -48.0% | – | – |
| Diluted EPS 1Y growth | 17.7% | 11.6% | 16.4% | -7.2% | -88.7% | 38.1% | 87.1% | – | – |
| Operating cash flow 1Y growth | -21.6% | 23.0% | 1.7% | 5.9% | -27.4% | -26.2% | -545.7% | – | – |
| Free cash flow 1Y growth | – | 23.3% | 3.9% | 6.1% | -14.5% | -33.6% | -891.1% | – | – |
| CapEx 1Y growth | – | -42.2% | -61.2% | -10.3% | -66.9% | 111.6% | 10.1% | – | – |
| CapEx 3Y CAGR | – | -41.4% | -51.4% | -14.4% | -8.3% | – | – | – | – |
| CapEx 5Y CAGR | – | -32.5% | -23.2% | – | – | – | – | – | – |
| Total assets 1Y growth | -37.9% | -36.8% | -30.5% | -24.0% | -21.0% | -13.9% | 141.3% | – | – |
| Total assets 3Y CAGR | -35.2% | -30.6% | -25.3% | -19.7% | 18.0% | – | – | – | – |
| Total assets 5Y CAGR | -30.4% | -25.7% | -2.8% | – | – | – | – | – | – |
| Total equity 1Y growth | -46.6% | -42.8% | -31.7% | -28.2% | -20.5% | -8.6% | 784.8% | -92.3% | – |
| Total equity 3Y CAGR | -40.7% | -34.5% | -27.0% | -19.5% | – | – | – | – | – |
| Total equity 5Y CAGR | -34.7% | -27.3% | – | – | – | – | – | – | – |
Every figure here is calculated from standardized financial statements — hover a row name for the formula — not reported by the company. Valuation multiples use the closing price at the end of that period, not today's price.